Reproductive Freedom for All is launching a $250,000 campaign targeting Sen. Susan Collins (R-Maine) over her role in confirming a key member of the Supreme Court majority that overturned Roe v. Wade, Axios has learned.
Why it matters: Collins is facing Maine voters for the first time since the fall of Roe — putting her pivotal 2018 vote to confirm Justice Brett Kavanaugh back at the center of one of the country's most competitive Senate races.
Health Secretary Robert F. Kennedy Jr.'s vaccine agenda is one of the biggest political liabilities hanging over Republicans, but his suspicion of the medical system is likely to endure with the GOP base.
Why it matters: Kennedy will one day leave public life, whether it's after the midterms or later, and it is an open question who — if anyone — will pick up where he left off merging vaccine skepticism with official health policy.
The nine new drug pricing deals the Trump administration announced with midsize manufacturers Monday came together despite fears within segments of the industry about how price concessions could affect smaller companies' bottom lines.
Why it matters: The administration has been pressuring midsize companies to fall in line with its pricing regime, as it expands the "most favored nation" deals it's already struck with 17 large drug manufacturers.
A new independent evaluation finds that leading AI models are far less likely than earlier versions to explicitly encourage suicide or reinforce delusions.
Yes, but: The study also found most models too willing toassist with suicide-related creative writing, farewell notes and other task-based requests even when a user's distress should have been apparent.
Why it matters: Saving the world with AI-designed cures is better than being blamed for ruining the environment or driving up Americans' utility bills.
